| Financial Year |
March 31 2023 |
| Monetary Funds |
748,474,021.75 |
| Held-for-trading Financial Assets |
863,095,199.66 |
| Notes Receivable |
50,590,948.68 |
| Accounts Receivable |
281,277,734.16 |
| Advances to Suppliers |
2,479,510.74 |
| Other Receivables |
4,608,352.77 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
199,015,658.27 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
8,274,586.23 |
| Total Current Assets |
2,219,880,839.07 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
105,602,539.70 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
141,258,556.41 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
4,142,141.58 |
| Deferred Income Tax Assets |
16,664,272.09 |
| Other Non-Current Assets |
551,011.00 |
| Sub-Total of Non-Current Assets |
277,088,864.05 |
| Total Assets |
2,496,969,703.12 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
87,497,080.38 |
| Accounts Payable |
114,942,754.75 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
16,203,467.03 |
| Taxes Payable |
15,340,886.50 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
3,395,405.29 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,042,857.70 |
| Other Current Liabilities |
6,286,614.66 |
| Sub-Total of Current Liabilities |
303,503,375.18 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
5,588,294.77 |
| Deferred Income Tax Liabilities |
3,450,965.04 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
16,990,968.86 |
| Total Liabilities |
320,494,344.04 |
| Paid-In Capital(Or Share Stock) |
151,800,000.00 |
| Capital Surplus |
1,221,480,465.30 |
| Surplus Reserve |
76,981,531.43 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
708,142,151.80 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,176,475,359.08 |
| Owner's Equity（Stockholder's Equity） |
2,176,475,359.08 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,496,969,703.12 |
